Last $120.36 USD
Change Today +5.23 / 4.55%
Volume 560.6K
As of 3:00 PM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert W. Duggan

Chairman and Chief Executive Officer, Pharmacyclics Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 3 different industries.

See Board Relationships
70--
As of Fiscal Year 2013

Background*

Mr. Robert W. Duggan, also known as Bob, has been the Chief Executive Officer of Pharmacyclics Inc. since February 12, 2009. Mr. Duggan served as Interim Chief Financial Officer of Pharmacyclics Inc. since October 31, 2008 and Interim Chief Executive Officer from September 2008 to February 2009. Mr. Duggan served as Chief Executive Officer of Computer Motion, Inc. since 1997. Mr. Duggan founded Robert W. Duggan & Associates. He served as Secretary at Artificial Life, ...

Read Full Background

Corporate Headquarters*

999 East Arques Avenue
Sunnyvale, California 94085

United States

Phone: 408-774-0330
Fax: 408-774-0340

Board Members Memberships*

Former Chairman of the Board of Directors and Chief Executive Officer
2003-2011
Former Director
2007-Present
Chairman and Chief Executive Officer

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCYC:US $120.45 USD +5.32

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMACYCLICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.